Targeted liposomes for cell death imaging and amplified drug delivery

RİCE, Douglas
Türkyılmaz, Serhan
PALUMBO, Rachael
SMİTH, Bradley D
The goal is to develop liposomes that have selective affinity for dead and dying cells, and then use the liposomes as targeted imaging agents for rapidly assessing the efficacy of anticancer therapies. A subsequent application is to use the liposomes to deliver anticancer drugs to tumors and initiate cell death processes that amplify the liposome targeting at later time points in the therapy. The liposome surface is decorated with 2% Zn-DPA-PEG2000-PE, an anchored phospholipid with an extended polyethylene chain that terminates with a zinc-dipicolylamine (Zn-DPA) targeting group. Previous studies with fluorescent Zn-DPA molecular probes have shown that they have high selective affinity for dead and dying cells. Specifically, they target the anionic phospholipid, phosphatidylserine (PS), a cell death biomarker that is exposed on the surface of dead and dying cells. Zn-DPA liposomes are composed of 2% Zn-DPA-PEG2000-PE, 67% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 30% cholesterol and 1% near-infrared fluorophore (DiR). Untargeted liposomes are composed of 69% POPC, 30% cholesterol and 1% DiR. The ability of Zn-DPA liposomes to target a chemical model of the PS cell death biomarker was assessed using a fluorescence quenching assay. These studies revealed that the PEG chains do not inhibit the affinity of the Zn-DPA units. In vitro fluorescence microscopy of several cancer model cell-lines (MDA-MB-213, Jurkat E6-1) showed that the Zn-DPA liposomes strongly stain dead and dying cancer cells that were treated with the anticancer agent etoposide. Multicolor imaging of dead and dying cells using the small molecule DPA probe PSVue™480 demonstrates that Zn-DPA liposomes co-localize to the dead cell periphery, a definitive feature of surface targeting. A rat thymus atrophy model was used to access the in vivo cell death targeting capability of Zn-DPA liposomes. Rats were dosed with intraperitoneal dexamethasone to induce thymocyte cell death. Zn-DPA and untargeted liposomes were intravenously injected into separate cohorts (n = 3) and after 24 hours, the rats were euthanized and their organs were excised and imaged. The uptake of targeted liposomes into the dying tissue was more than 4-fold greater than the untargeted liposome system. In summary, liposomes coated with multiple copies of Zn-DPA targeting groups are effective cell death imaging agents for fluorescence microscopy and they can target dead and dying tissue in living animals. With further development, these targeted liposomes have potential utility for rapid clinical evaluation of anticancer drug efficacy in individual patients.
Citation Formats
D. RİCE, S. Türkyılmaz, R. PALUMBO, K. HARMATYS, and B. D. SMİTH, “Targeted liposomes for cell death imaging and amplified drug delivery,” 2013, vol. 54, Accessed: 00, 2020. [Online]. Available: